[引用][C] Cerebrum and cardiac protection with allopurinol

R Stegeman, M Nijman, JMPJ Breur, F Groenendaal… - Neonatal Cardiac Disease, 2022

Management of hypertension addressing hyperuricaemia: introduction of nano-based approaches

K Girigoswami, R Arunkumar, A Girigoswami - Annals of Medicine, 2024 - Taylor & Francis
… XO transforms allopurinol into its primary metabolite, oxypurinol. Allopurinol and oxypurinol
share structural similarities with the purine bases HPX and XAN, respectively ( Figure 2 ). …

Pharmacogenomics for primary care: an overview

V Rollinson, R Turner, M Pirmohamed - Genes, 2020 - mdpi.com
allopurinol-associated SCARs demonstrated that oxypurinol … but allopurinol and febuxostat
did not, indicative of oxypurinol… granulysin in response to oxypurinol likely participate in the …

On the clinical pharmacology of reactive oxygen species

AI Casas, C Nogales, HAM Mucke, A Petraina… - Pharmacological …, 2020 - ASPET
Reactive oxygen species (ROS) have been correlated with almost every human disease. Yet
clinical exploitation of these hypotheses by pharmacological modulation of ROS has been …

CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass …

R Stegeman, M Nijman, JMPJ Breur, F Groenendaal… - Trials, 2022 - Springer
… neonates received allopurinol PFI … pharmacokinetic data of allopurinol, oxypurinol,
hypoxanthine, xanthine, and uric acid and to establish if expected target concentrations of allopurinol

Safety and tolerability of available drugs for hyperuricemia: a critical review and an update on recent developments.

G Fang, W Li, J Zhang, Q Ke, X Zhu… - Journal of Chinese …, 2022 - search.ebscohost.com
Oxypurinol Oxypurinol is an active metabolite of allopurinol oxidation and has a stronger
inhibitory … Its drug action and curative effect are similar to those of allopurinol, while the adverse …

Allopurinol lowers serum urate but does not reduce oxidative stress in CKD

M Sun, N Hines, D Scerbo, J Buchanan, C Wu… - Antioxidants, 2022 - mdpi.com
… The effects of allopurinol and its downstream metabolite, oxypurinol, on pyrimidine synthesis
include inhibition of orotodine monophosphate decarboxylase (OMD) [51]. The inhibition of …

What's new on the front-line of gout pharmacotherapy?

KEG Blake, JL Saag, KG Saag - Expert Opinion on …, 2022 - Taylor & Francis
Allopurinol is metabolized into the active metabolite oxypurinol primarily by the enzyme …
Allopurinol has a half-life of 1.2 hours, whereas oxypurinol’s half-life is 23 hrs. The active …

Effect of glycation of bovine serum albumin on the interaction with xanthine oxidase inhibitor allopurinol: Spectroscopic studies and molecular modeling

N Rahman, N Khalil - Journal of Molecular Liquids, 2022 - Elsevier
… The action pathway of allopurinol is to inhibit the functioning … also converts allopurinol to
its active metabolite oxypurinol (… affects the pharmacokinetics and pharmacodynamics of the …

Wastewater-based prevalence trends of gout in an Australian community over a period of 8 years

F Ahmed, B Tscharke, JW O'Brien, Q Zheng… - Science of the Total …, 2021 - Elsevier
… is metabolised into oxypurinol and … oxypurinol in wastewater. A total of 180 wastewater
samples collected between 2012 and 2019 were analysed for oxypurinol to estimate allopurinol